Nifty
Sensex
:
:
14281.30
48564.27
-152.40 (-1.06%)
-470.40 (-0.96%)

Pharmaceuticals & Drugs - Domestic

Rating :
73/99  (View)

BSE: 539523 | NSE: ALKEM

3047.55
-57.15 (-1.84%)
18-Jan-2021 | 3:47PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  3080.00
  •  3114.70
  •  2988.70
  •  3104.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  224661
  •  6846.66
  •  3149.00
  •  1881.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 36,418.90
  • 24.88
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 37,046.67
  • 0.82%
  • 5.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.43%
  • 0.20%
  • 20.03%
  • FII
  • DII
  • Others
  • 4.08%
  • 12.61%
  • 0.65%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.31
  • 11.12
  • 9.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.79
  • 11.54
  • 7.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.32
  • 8.73
  • 21.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 28.29
  • 29.20

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 4.67
  • 4.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 19.77
  • 19.57

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
2,362.80
2,264.03
4.36%
2,003.49
1,849.50
8.33%
2,048.99
1,853.03
10.58%
2,181.84
1,926.32
13.26%
Expenses
1,762.31
1,811.44
-2.71%
1,470.31
1,585.00
-7.24%
1,745.96
1,619.19
7.83%
1,728.57
1,612.77
7.18%
EBITDA
600.49
452.59
32.68%
533.18
264.50
101.58%
303.03
233.84
29.59%
453.27
313.55
44.56%
EBIDTM
25.41%
19.99%
26.61%
14.30%
14.01%
12.62%
20.77%
16.28%
Other Income
35.54
31.42
13.11%
43.50
17.47
149.00%
27.47
28.83
-4.72%
27.86
7.58
267.55%
Interest
18.04
17.75
1.63%
17.10
16.12
6.08%
14.15
6.59
114.72%
17.04
15.38
10.79%
Depreciation
70.24
56.40
24.54%
66.83
55.83
19.70%
81.05
57.27
41.52%
59.48
47.69
24.72%
PBT
547.75
409.86
33.64%
492.75
210.02
134.62%
235.30
198.81
18.35%
404.61
258.06
56.79%
Tax
66.24
29.34
125.77%
69.56
22.73
206.03%
43.76
28.31
54.57%
14.65
52.61
-72.15%
PAT
481.51
380.52
26.54%
423.19
187.29
125.95%
191.54
170.50
12.34%
389.96
205.45
89.81%
PATM
20.38%
16.81%
21.12%
10.13%
7.11%
9.20%
17.87%
10.67%
EPS
39.49
31.02
27.30%
35.30
15.51
127.60%
28.29
14.00
102.07%
31.95
16.94
88.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
8,597.12
8,344.36
7,357.19
6,391.84
5,687.53
4,924.84
3,743.35
3,126.00
2,495.23
2,015.64
1,690.79
Net Sales Growth
8.92%
13.42%
15.10%
12.38%
15.49%
31.56%
19.75%
25.28%
23.79%
19.21%
 
Cost Of Goods Sold
7,146.33
2,959.14
2,602.77
1,986.45
1,807.71
1,630.87
1,453.41
1,168.05
866.74
645.76
597.04
Gross Profit
1,450.79
5,385.22
4,754.42
4,405.39
3,879.82
3,293.97
2,289.94
1,957.95
1,628.49
1,369.88
1,093.75
GP Margin
16.88%
64.54%
64.62%
68.92%
68.22%
66.88%
61.17%
62.63%
65.26%
67.96%
64.69%
Total Expenditure
6,707.15
6,870.97
6,242.42
5,382.92
4,688.58
4,071.59
3,321.52
2,716.05
2,132.78
1,640.43
1,404.20
Power & Fuel Cost
-
130.14
121.48
112.64
86.34
66.33
53.31
60.33
53.17
50.68
37.78
% Of Sales
-
1.56%
1.65%
1.76%
1.52%
1.35%
1.42%
1.93%
2.13%
2.51%
2.23%
Employee Cost
-
1,505.49
1,362.46
1,191.64
1,003.85
861.08
645.87
531.56
412.29
303.45
267.09
% Of Sales
-
18.04%
18.52%
18.64%
17.65%
17.48%
17.25%
17.00%
16.52%
15.05%
15.80%
Manufacturing Exp.
-
765.43
806.17
838.87
692.26
550.16
367.58
305.99
264.84
234.61
195.99
% Of Sales
-
9.17%
10.96%
13.12%
12.17%
11.17%
9.82%
9.79%
10.61%
11.64%
11.59%
General & Admin Exp.
-
525.62
512.52
469.90
377.69
331.27
238.45
184.73
180.17
139.46
106.32
% Of Sales
-
6.30%
6.97%
7.35%
6.64%
6.73%
6.37%
5.91%
7.22%
6.92%
6.29%
Selling & Distn. Exp.
-
854.48
726.21
675.43
596.44
503.69
434.56
367.31
295.39
226.31
167.01
% Of Sales
-
10.24%
9.87%
10.57%
10.49%
10.23%
11.61%
11.75%
11.84%
11.23%
9.88%
Miscellaneous Exp.
-
130.67
110.81
107.99
124.29
128.19
128.34
98.08
60.18
40.16
167.01
% Of Sales
-
1.57%
1.51%
1.69%
2.19%
2.60%
3.43%
3.14%
2.41%
1.99%
1.95%
EBITDA
1,889.97
1,473.39
1,114.77
1,008.92
998.95
853.25
421.83
409.95
362.45
375.21
286.59
EBITDA Margin
21.98%
17.66%
15.15%
15.78%
17.56%
17.33%
11.27%
13.11%
14.53%
18.61%
16.95%
Other Income
134.37
104.22
87.70
115.42
112.01
239.71
181.04
165.35
167.17
145.28
113.42
Interest
66.33
65.06
54.63
55.33
45.16
71.24
81.11
93.08
88.23
58.10
41.23
Depreciation
277.60
252.76
193.18
143.03
101.17
93.31
70.94
52.26
39.79
29.03
27.43
PBT
1,680.41
1,259.79
954.66
925.98
964.63
928.41
450.82
429.96
401.60
433.36
331.35
Tax
194.21
110.48
181.02
287.56
59.96
176.18
59.23
-5.36
17.97
27.52
35.57
Tax Rate
11.56%
8.77%
18.96%
31.05%
6.22%
18.98%
13.14%
-1.25%
4.47%
6.35%
10.73%
PAT
1,486.20
1,127.07
760.51
630.94
892.03
741.59
391.59
435.32
383.82
406.54
295.59
PAT before Minority Interest
1,467.59
1,149.31
773.64
638.42
904.67
752.23
391.59
435.32
383.63
405.84
295.78
Minority Interest
-18.61
-22.24
-13.13
-7.48
-12.64
-10.64
0.00
0.00
0.19
0.70
-0.19
PAT Margin
17.29%
13.51%
10.34%
9.87%
15.68%
15.06%
10.46%
13.93%
15.38%
20.17%
17.48%
PAT Growth
57.48%
48.20%
20.54%
-29.27%
20.29%
89.38%
-10.05%
13.42%
-5.59%
37.54%
 
Unadjusted EPS
124.26
94.24
63.59
52.75
74.58
62.01
32.74
36.40
32.09
33.99
24.71

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
6,160.67
5,439.34
4,863.77
4,467.64
3,691.96
3,002.63
2,584.97
2,177.31
1,820.05
1,433.69
Share Capital
23.91
23.91
23.91
23.91
23.91
23.91
11.96
11.96
11.96
11.96
Total Reserves
6,135.40
5,413.93
4,838.87
4,443.34
3,668.03
2,978.72
2,573.01
2,165.35
1,808.09
1,421.73
Non-Current Liabilities
-541.52
-288.92
-358.61
-400.78
-306.15
197.02
323.92
361.67
524.89
434.40
Secured Loans
148.93
219.80
122.12
175.01
112.49
33.43
232.25
255.57
308.97
246.26
Unsecured Loans
10.31
11.50
8.61
6.55
10.97
0.00
0.00
0.02
0.00
0.00
Long Term Provisions
222.04
173.72
150.27
102.17
82.96
66.58
42.29
44.30
179.99
162.14
Current Liabilities
3,243.31
2,217.53
2,383.31
1,689.69
1,537.60
2,005.98
1,402.58
1,731.80
1,120.59
981.86
Trade Payables
954.05
962.25
960.71
741.37
580.48
465.93
305.73
287.59
276.03
167.69
Other Current Liabilities
555.47
428.08
520.04
339.25
366.01
327.06
201.28
187.74
111.47
87.39
Short Term Borrowings
1,503.51
671.27
761.27
472.37
464.17
1,128.57
845.22
1,210.17
670.31
663.10
Short Term Provisions
230.28
155.93
141.29
136.70
126.94
84.42
50.35
46.30
62.78
63.68
Total Liabilities
9,010.76
7,500.56
7,010.02
5,871.78
5,018.43
5,291.28
4,311.47
4,270.78
3,465.72
2,851.77
Net Block
2,908.01
2,530.44
2,283.59
1,797.04
1,449.54
1,374.34
1,170.01
1,072.12
919.17
692.73
Gross Block
3,606.95
3,026.08
2,603.78
1,977.20
1,538.64
1,744.89
1,170.01
1,072.12
919.17
692.73
Accumulated Depreciation
698.94
495.64
320.19
180.16
89.10
370.55
0.00
0.00
0.00
0.00
Non Current Assets
3,514.73
3,284.43
2,996.80
2,954.64
2,249.73
2,953.23
2,709.33
2,114.56
2,153.43
1,313.22
Capital Work in Progress
362.97
492.96
380.97
299.26
172.42
110.69
0.00
0.00
0.00
0.00
Non Current Investment
91.50
95.74
98.45
259.44
234.39
419.73
338.24
410.33
298.91
6.10
Long Term Loans & Adv.
105.57
118.64
141.37
193.07
142.35
542.17
418.40
339.39
258.82
153.98
Other Non Current Assets
46.68
46.65
92.42
405.83
251.03
506.30
782.68
292.72
676.53
460.41
Current Assets
5,496.03
4,216.13
4,013.22
2,917.14
2,768.70
2,338.05
1,602.14
2,156.22
1,312.29
1,538.55
Current Investments
169.89
227.88
345.82
293.56
274.18
61.05
249.77
67.31
23.78
47.70
Inventories
1,818.82
1,499.87
1,442.19
1,206.00
909.37
784.23
620.33
553.96
384.92
250.87
Sundry Debtors
1,649.36
1,248.41
1,080.50
713.64
567.51
527.08
366.93
318.21
246.61
171.02
Cash & Bank
1,092.21
661.60
576.78
399.26
780.90
790.76
206.29
995.45
513.81
989.82
Other Current Assets
765.75
173.37
177.30
133.33
236.74
174.93
158.82
221.29
143.17
79.14
Short Term Loans & Adv.
482.24
405.00
390.63
171.35
141.30
114.85
110.04
115.29
80.24
40.32
Net Current Assets
2,252.72
1,998.60
1,629.91
1,227.45
1,231.10
332.07
199.56
424.42
191.70
0.00
Total Assets
9,010.76
7,500.56
7,010.02
5,871.78
5,018.43
5,291.28
4,311.47
4,270.78
3,465.72
2,851.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
585.08
779.65
266.04
471.14
725.83
328.14
290.01
78.05
159.05
147.93
PBT
1,259.79
954.66
925.98
964.63
928.41
514.16
429.96
401.60
433.36
331.35
Adjustment
255.87
216.37
116.47
33.02
-14.42
15.89
7.48
-30.64
-32.93
-17.61
Changes in Working Capital
-647.20
-140.27
-573.24
-262.55
10.05
-96.27
-36.37
-182.68
-144.78
-99.22
Cash after chg. in Working capital
868.46
1,030.76
469.21
735.10
924.04
433.78
401.07
188.28
255.65
214.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-283.38
-251.11
-203.17
-263.96
-198.21
-105.64
-111.06
-110.23
-96.60
-66.59
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-741.35
-316.39
-357.23
-285.93
202.27
-237.00
350.44
-403.52
-247.50
-822.79
Net Fixed Assets
-310.63
-342.15
-531.27
-390.07
160.79
-111.90
-103.11
-213.73
-206.97
Net Investments
-260.44
-151.10
-26.86
-359.97
-87.11
-129.77
-361.40
-207.20
-318.96
Others
-170.28
176.86
200.90
464.11
128.59
4.67
814.95
17.41
278.43
Cash from Financing Activity
79.15
-378.94
84.56
-137.88
-927.27
-51.79
-599.94
355.64
-11.07
778.87
Net Cash Inflow / Outflow
-77.12
84.32
-6.63
47.33
0.83
39.35
40.51
30.17
-99.52
104.01
Opening Cash & Equivalents
249.05
166.71
166.63
127.03
123.75
100.82
57.31
26.35
123.96
19.98
Closing Cash & Equivalent
175.94
249.05
166.71
166.63
127.05
139.60
100.82
57.31
26.35
123.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
515.21
454.86
406.76
373.67
308.82
251.16
216.13
182.05
152.18
0.00
ROA
13.92%
10.66%
9.91%
16.61%
14.59%
8.16%
10.14%
9.92%
12.85%
10.37%
ROE
19.82%
15.02%
13.69%
22.18%
22.47%
14.02%
18.28%
19.19%
24.95%
20.63%
ROCE
18.60%
16.49%
17.86%
21.31%
23.09%
13.26%
14.06%
14.96%
19.02%
15.90%
Fixed Asset Turnover
3.74
3.80
3.75
3.33
3.07
2.65
2.89
2.59
2.57
2.49
Receivable days
42.66
39.69
38.15
39.95
39.57
42.27
38.62
40.02
36.80
36.14
Inventory Days
48.86
50.14
56.31
65.96
61.23
66.41
66.19
66.53
56.02
53.01
Payable days
52.06
60.17
61.04
52.36
49.96
45.83
42.61
49.36
50.29
47.05
Cash Conversion Cycle
39.46
29.66
33.42
53.55
50.84
62.85
62.19
57.20
42.53
42.10
Total Debt/Equity
0.28
0.17
0.21
0.15
0.18
0.43
0.44
0.71
0.55
0.00
Interest Cover
20.36
18.48
17.74
22.36
14.03
6.56
5.62
5.55
8.46
9.04

Annual Reports:


News Update


  • Alkem Laboratories - Quarterly Results
    6th Nov 2020, 13:38 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.